HIGHLIGHTS
- who: Youngwoo Jeon and collaborators from the National Taiwan University, Taiwan have published the Article: Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study, in the Journal: (JOURNAL)
- what: Since the main purpose of this study was to determine whether the use of pegfilgrastim during administration of R-FC chemotherapy could reduce the incidence of grade 3-4 neutropenia: All patients in the study cohort were previously administrated prophylactic pegylated filgrastim, and patients with historical cohort received non-pegylated filgrastim for the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.